Abiopharma

🔍 LARSON MATTHEW PAUL (Executive)

Company: Slide Insurance Holdings, Inc. (SLDE)

Report Date: 2026-04-16

Detailed Transactions and Holdings:

• Acquired 8,750 shares of Common Stock at $0.79 per share (Direct)
  Date: 2026-04-16 | Code: M | equity_swap_involved: false | shares_owned_after: 8,750.00 | transaction_form_type: 4
• Sold 8,750 shares of Common Stock at $19.0 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
• Acquired 11,250 shares of Common Stock at $0.79 per share (Direct)
  Date: 2026-04-20 | Code: M | equity_swap_involved: false | shares_owned_after: 11,250.00 | transaction_form_type: 4
• Sold 11,250 shares of Common Stock at $19.39 per share (Direct)
  Date: 2026-04-20 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 8,750 shares of Stock Option (Right to Buy) at $0.79 per share (Derivative)
  Date: 2026-04-16 | Code: M | Expires: 2032-02-21 | equity_swap_involved: false | shares_owned_after: 12,500.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 11,250 shares of Stock Option (Right to Buy) at $0.79 per share (Derivative)
  Date: 2026-04-20 | Code: M | Expires: 2032-02-21 | equity_swap_involved: false | shares_owned_after: 1,250.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 4, 2025.
• F2: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.97 to $19.91 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
• F3: These stock options are fully vested and exercisable.